Author Archives: 2bPrecise

Handelsman Family Practice Implements 2bPrecise™ Pharmacogenomics

Pittsburgh physicians seek to improve medication safety, efficacy for patients RALIEGH, NC – December 3, 2020 – Handelsman Family Practice, which provides care to patients in southeast Pittsburgh, has implemented the 2bPrecise pharmacogenomics (PGx) solution. The solution makes patient genomic … Read More

San Francisco Otolaryngology Selects 2bPrecise

Leading Bay-area ENT group to launch precision medicine program, beginning with pharmacogenomics RALEIGH, NC—Nov. 11, 2020—San Francisco Otolaryngology has selected the 2bPrecise™ platform as the foundation for its precision medicine strategy, beginning with pharmacogenomics (PGx) and potentially expanding to additional … Read More

Vidence and 2bPrecise Announce Strategic Partnership to Unleash the Power of Genomic Data in Precision Oncology

Focus on providing Vidence Consortium Fellows with comprehensive genomic information and point-of-care tools to enhance clinical decision making, improve outcomes for oncology patients Boca Raton, FL and Raleigh, NC – October 27, 2020 – Vidence, an oncology informatics company, has … Read More

2bPrecise wins industry innovation award

Fierce Healthcare honors the precision medicine platform for clinical information management capabilities Raleigh, NC, Sept. 16, 2020 – Fierce Healthcare released its annual Fierce Innovation Report this week, naming 2bPrecise the industry’s top clinical information management solution. The intent of … Read More

Righting Wrongs in Precision Oncology Today: Incorporating Informatics to Avoid Missed Opportunities

Patients continue to pay the price for missed opportunities that could shorten the disease-burden timeline and improve outcomes. … Read More

Clinical Use Cases: Pharmacogenomic Results Within the EHR Workflow

Results realized by providers who have integrated pharmacogenomic (PGx) test results within their EHR workflows. … Read More

2bPrecise Releases V3.0 With Advanced Precision Oncology, Germline and Pharmacogenomic Capabilities

Key enhancements include point-of-care tools enabling oncologists to identify and act upon germline information uncovered during tumor profiling PITTSBURGH, PA – July 23, 2020 – The latest update to the 2bPrecise precision health platform includes functionality to help oncologists identify … Read More

Telegenetics helps independents thrive in COVID-fueled environment

Read More

Top 8 Precision Medicine Companies in the USA

Read More

Cancer Screening Leaps Forward

Read More